Mammalian target of rapamycin inhibitors are associated with lower rates of hepatocellular carcinoma recurrence after liver transplantation: a systematic review
2016 ◽
Vol 100
(8)
◽
pp. e43-e44
◽
2017 ◽
Vol 21
(4)
◽
pp. 205
◽
2015 ◽
Vol 47
(4)
◽
pp. 324-330
◽
2020 ◽
Vol 12
(4)
◽
pp. 149-158